USA Equities Corp's QHSLab Digital Health Platform Strategy is Backed by Latest Research Published in the Journal of the American Medical Association (JAMA)
January 07, 2022 08:30 ET
|
USA Equities Corp
The JAMA research found that digital health interventions supporting patient self-management improves primary care for patients with multiple chronic conditions.QHSLab supports medical decision making...
USA Equities Corp. Introduces AllergiQT™ – Quick Test, Further Expanding Market Presence
November 29, 2021 08:00 ET
|
USA Equities Corp
FDA-cleared and Easily Administered Skin Test for Environmental and Food Allergens; AllergiQT™ – Quick Test Targets Non-Allergy Specialists in Primary Care SettingsStrengthens USA Equities...
USA Equities Corp. Announces Third Quarter 2021 Financial Results And Conversion of Secured Convertible Promissory Note
November 16, 2021 07:30 ET
|
USA Equities Corp
● Revenue Surpassed $1 million for Nine Months of 2021 Compared to $0 for the Same Period 2020 ● Gross Margin of 48% in Q3 Increased 290 Basis Points Versus Q2 2021 ● Issuance of 76,923 Shares...
USA Equities Corp. Launches Q-Scale Product to Meet Growing Mental Health End Market Demand
October 19, 2021 08:30 ET
|
USA Equities Corp
Strengthening Business Model and Expanding Product Portfolio in Large Addressable End MarketQ-Scale Represents a Compelling and Reimbursable Value Proposition for USAQ’s Physician ClientsFurther...
USA Equities Corp. Announces Strong Second Quarter 2021 Results
August 17, 2021 08:30 ET
|
USA Equities Corp
Second Quarter 2021 Financial Results In-Line with July Pre-AnnouncementSuccessful $750,000 Capital Raise Increases Financial Flexibility to Execute on Growth StrategyAcquired AllergiEnd® Assets...
USA Equities Corp. Announces Strong Second Quarter 2021 Financial Results
July 15, 2021 07:30 ET
|
USA Equities Corp
● Revenue Grew 50% to $456,219 Compared to Q1 2021 ● Gross Margin of 46% Increased 164 Basis Points Versus Q1 2021 ● Strengthening of Company Financial Position and Strategic Relationships West Palm...
USA Equities Corp. Acquires AllergiEnd®Assets
June 24, 2021 07:00 ET
|
USA Equities Corp
●Acquisition Strengthens USAQ Business Model and Strategic Position●Purchase includes AllergiEnd® Method Patent, Trademark and Website●AllergiEnd®’s Product Portfolio Favorably Aligned with Industry...
USA Equities Corp Announces Co-Promotion Agreement with ENP Network for AllergiEnd® and Upcoming University of Miami CME Workshop
June 09, 2021 08:00 ET
|
USA Equities Corp
-Further Expanding Independent Practitioner Network and Industry Visibility- West Palm Beach, FL, June 09, 2021 (GLOBE NEWSWIRE) -- USA Equities Corp. (OTCQB: USAQ), a company focused on...
USA Equities Corp. Reports First Quarter 2021 Financial Results and Announces Upcoming Presentation at the University of Miami
May 18, 2021 07:00 ET
|
USA Equities Corp
● Substantial Sequential Increase in Revenue and Gross Margin ● Growth in Customer Base and Revenue Per Customer Compared to Q4 2020 ● Company Expects Sequential Increase in Gross Margin in Q2...
USA Equities Corp (USAQ) Announces Newest Advisory Board Members in First Quarter 2021
February 17, 2021 08:00 ET
|
USA Equities Corp
WEST PALM BEACH, FL, Feb. 17, 2021 (GLOBE NEWSWIRE) -- USA EQUITIES CORP. (OTCQB: USAQ) (the “Company,” “we,” or “our”) is focused on enabling primary care physicians (PCP’s) to increase their...